Posts Tagged: Canada
ScarX announces approval for trial of first clinically-promising scar reduction cream
Toronto, August 18, 2016 – Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a first-of-its-kind topical treatment developed to significantly reduce surgical scarring.
This announcement was covered in Yahoo Finance, The Canadian Business Journal, Global News Wire, and BioSpace.
Applied immediately after surgical wound closure, SCX-001 reduces the amount of scar tissue that develops during the body’s natural healing process. The 24-subject Phase I clinical trial will be conducted at ...
Read more
MaRS Innovation highlighted in the ExcelleNCE newsletter
MaRS Innovation was highlighted in the Networks of Centres of Excellence (NCE) newsletter on Wednesday, June 22. The article is titled, "MaRS Innovation revolutionizes approach to commercialization, " and discusses the success of the MaRS Innovation commercialization model.
The article mentions companies such as ScarX Therapeutics, a spin-off of MI and Toronto’s Hospital for Sick Children that is commercializing a topical prescription cream. It also talks about Encycle Therapeutics, a Toronto biotechnology start-up from the University of Toronto, that has developed a fast, ...
Read more
Toronto’s QD Solar sole Canadian among five winners of solar technology challenge
QD Solar, a Canadian start-up company, is one of the five winners of the SunRISE TechBridge Challenge. They will receive support from Greentown Launch acceleration and DSM Partnership/Investment to help move forward in developing their technology and bring it closer to market.
QD Solar is developing the next generation photovoltaic cells using cutting-edge colloidal quantum dot technology. QD Solar’s proprietary quantum dot-based solar cells use nano-engineered, low-cost materials that can absorb this otherwise wasted infrared light. The world-leading underlying solar technology was developed in ...
Read more
Dr. Raphael Hofstein in Biotechnology Focus: Canada’s Contagiously Creative Life Sciences Sector
Biotechnology Focus, a compendium of the Canadian life sciences industry, has published the following guest column by Dr. Raphael Hofstein, MaRS Innovation’s president & CEO, and Elizabeth Monier-Williams, director of marketing and communications.
There’s a historical trend in Canadian culture with far-reaching effects for the way we do business, ranging from entertainment to academia to science. Namely, it’s that until quite recently, Canadians weren’t into cultivating national star systems. [1]
As Gideon Hayden recently wrote for TechCrunch, if you’re a Canadian tall poppy ...
Read more
The BBC features Flybits and Ryerson University’s Digital Media Zone
"With massive amounts of cash being pumped into development by Google, Facebook, Microsoft and context-aware startups such as Flybits, the PA in everybody’s pocket could soon be a reality," Nick Clayton wrote in BBC Capital about virtual personal assistants (Siri, Cortana, Alexa, etc.).
Flybits was founded by Hossein Rahnama, Research and Innovation Director at Ryerson University Digital Media Zone in partnership with MaRS Innovation. Flybits is a software solution that makes it simple to personalize an app's behaviour. Digital marketers can use this information to then ...
Read more
Israel’s BioLineRx and Canada’s MaRS Innovation sign framework collaboration agreement
Agreement signed as part of Ontario's life sciences trade mission to Israel
TEL AVIV and TORONTO (May 16, 2016) – BioLineRx Ltd. a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has signed a framework collaboration agreement with MaRS Innovation, the commercialization agent for 15 of Toronto's top academic institutions.
Under the terms of the agreement, BioLineRx intends to review innovative projects and assets of start-up companies originating from MaRS Innovation's members to identify in-licensing, co-development or other ...
Read more
Johnson & Johnson Innovation Opens JLABS @ Toronto
TORONTO (May 11, 2016) – Johnson & Johnson Innovation LLC, today announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies. The new JLABS facility can accommodate up to 50 start-ups and opens with 22 companies that represent a range of sectors including therapeutics, medical devices and consumer health ...
Read more
Ryerson University to host Dr. Daniel Kraft on Future of Health and Medicine
MaRS Innovation and the Ontario Centres of Excellence among the event's sponsors
On Tuesday, May 31, 2016, Diane Francis, the first woman editor of a national daily newspaper in Canada and a distinguished professor at the Ted Rogers School of Management, will guide a conversation that begins with a keynote address by Dr. Daniel Kraft, one of the world’s foremost health experts and innovators whose ideas and work are shaping digital health.
Dr. Daniel Kraft will be sharing his insights and experiences as ...
Read more
UTEST gets a mention in TechVibes piece on Canada’s growing start-up scene
TechVibes gave UTEST, an incubator program jointly run by MaRS Innovation and the University of Toronto, a mention in Laura Leslie's "Canada’s Startup Communities Shining Brighter Than the California Sun," published November 24, 2014, which explores the ecosystem-wide supports in place to encourage entrepreneurship in Canada.
Leslie writes:
Silicon Valley may be the first place that comes to mind when you think of tech startups, but when considering resources, financial support, and a welcoming atmosphere, Canada has been steadily putting itself on the map. ...
Read more
Dr. Rafi Hofstein in Biotechnology Focus: What will it take to regain Canada’s biotechnology leadership?
Biotechnology Focus, a compendium of the Canadian life sciences industry, has published a guest column by MaRS Innovation President & CEO, Dr. Raphael Hofstein.
The article explores the role life sciences assets, financing and talented management--the three Ms--must play in revitalizing Canada's biotechnology sector:
At the close of the 20th century, Canada was perceived as a key contributor to the success of the global biotech voyage.
You know what happened next: the mechanisms to fund early ventures collapsed together with the collapse of the ...
Read more